Disc Medicine (IRON) Change in Accured Expenses (2020 - 2026)

Disc Medicine (IRON) has reported Change in Accured Expenses for 7 consecutive years, with $2.1 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Change in Accured Expenses rose 75.41% year-over-year to $2.1 million; the TTM figure through Jun 2026 stood at $2.7 million (up 110.36% YoY), while the FY2025 annual figure was $6.9 million, up 309.4% from the prior year.
• Change in Accured Expenses grew to $2.1 million in Q2 2026 per IRON's latest filing, from -$8.7 million in the prior quarter.
• Across five years, Change in Accured Expenses topped out at $5.0 million in Q3 2025 and bottomed at -$8.7 million in Q1 2026.
• Historically, Change in Accured Expenses has averaged $290222.2 across 5 years, with a median of $952000.0 in 2023.
• Annual changes were most pronounced in 2022 — Change in Accured Expenses soared 3824.53% — and 2023, when it plunged 11477.78%.
• Disc Medicine's Change in Accured Expenses stood at $2.0 million in 2022, then jumped by 36.17% to $2.7 million in 2023, then declined by 13.39% to $2.3 million in 2024, then jumped by 90.98% to $4.4 million in 2025, then slumped by 53.8% to $2.1 million in 2026.
• Business Quant data shows IRON's Change in Accured Expenses at $2.1 million in Q2 2026, -$8.7 million in Q1 2026, and $4.4 million in Q4 2025.